UNSPSC 51285315: Nifurmazole

This classification denotes an anti-infective agent with the molecular formula C11H10N4O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) LOF2A7032C, chemically known as 3-(hydroxymethyl)-1-(3-(5-nitro-2-furyl)allylidenamino)-2,4-imidazolidindion but more generally known as nifurmazole, which bears US NIH Compound Identifier 72086. European Medicines Agency schedules Nifurmazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09268MIG.

UNSPSC 51285315 Nifurmazole is a Commodity code that in practice maps to state and local procurement of pharmaceutical products, medical supplies, and related healthcare consumables. Recent solicitations under this code show state and local governments buying naloxone and drug deactivation systems, medical and first aid supplies for emergency response, and generic pharmaceuticals through cooperative purchasing arrangements. The issuing bodies span county health departments, municipal fire services, state health and human services agencies, and multistate cooperative purchasing alliances serving state and local facilities. Work solicited ranges from direct product procurement with specific unit and quantity requirements to vendor qualification and capacity-building for direct-to-manufacturer pharmacy programs and cooperative pharmaceutical supply agreements.

Activity under the code appears concentrated in Florida and Minnesota, with participation from Texas HHS and multistate cooperative purchasing entities serving Oregon and other member jurisdictions. Seminole County, Florida issued IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually for community health initiatives with quarterly deliveries to the Seminole County Community Health Building. The City of Tampa issued IFB 26P00145 (posted March 25, 2026, due March 13, 2026) for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division with an estimated contract value of $700,000.00, structured as a sheltered market opportunity for certified Small Local Business Enterprises with a 5 percent bid discount. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products for participating state and local government facilities including Oregon, with awards effective July 1, 2026. The Texas HHS Commission issued RFI HHS0017013 (posted April 3, 2026, due April 3, 2026) as a preliminary market intelligence tool to solicit vendor capabilities for a direct-to-manufacturer pharmacy benefit program before issuing a formal RFP.